News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
147,237 Results
Type
Article (8413)
Company Profile (41)
Press Release (138782)
Multimedia
Podcasts (30)
Webinars (6)
Section
Business (46559)
Career Advice (93)
Deals (6548)
Drug Delivery (13)
Drug Development (25490)
Employer Resources (13)
FDA (3420)
Job Trends (3733)
News (74623)
Policy (4964)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Elite (1)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (385)
Accelerated approval (20)
ADA (4)
Adcomms (16)
Allergies (15)
Alliances (12243)
ALS (44)
Alzheimer's disease (232)
Antibody-drug conjugate (ADC) (437)
Approvals (3683)
Artificial intelligence (266)
ASCO (333)
Autoimmune disease (127)
Automation (11)
Bankruptcy (55)
Best Places to Work (3413)
BIO (28)
BIOSECURE Act (1)
Biosimilars (128)
Biotechnology (36)
Bladder cancer (164)
Brain cancer (62)
Breast cancer (635)
Cancer (4865)
Cardiovascular disease (46)
Career advice (88)
Career pathing (5)
CAR-T (174)
CDC (5)
Celiac Disease (1)
Cell therapy (363)
Cervical cancer (33)
Clinical research (23411)
Collaboration (935)
Company closure (2)
Compensation (293)
Complete response letters (20)
COVID-19 (484)
CRISPR (33)
C-suite (452)
Cystic fibrosis (8)
Data (3390)
Decentralized trials (1)
Denatured (4)
Depression (11)
Dermatology (21)
Diabetes (61)
Diagnostics (1989)
Digital health (12)
Diversity (2)
Diversity, equity & inclusion (5)
Drug discovery (139)
Drug pricing (27)
Drug shortages (2)
Duchenne muscular dystrophy (38)
Earnings (15701)
Editorial (19)
Employer branding (2)
Employer resources (14)
Events (27856)
Executive appointments (382)
FDA (4625)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (1)
Frontotemporal dementia (2)
Funding (460)
Gene editing (53)
Generative AI (24)
Gene therapy (116)
GLP-1 (150)
Government (556)
Guidances (103)
Healthcare (4518)
Hematology (107)
HIV (13)
Huntington's disease (4)
IgA nephropathy (18)
Immunology and inflammation (104)
Immuno-oncology (118)
Indications (108)
Infectious disease (551)
Inflammatory bowel disease (52)
Inflation Reduction Act (3)
Influenza (28)
Intellectual property (77)
Interviews (13)
IPO (3244)
IRA (8)
Job creations (505)
Job search strategy (73)
JPM (26)
Kidney cancer (24)
Labor market (10)
Layoffs (148)
Leadership (9)
Legal (520)
Liver cancer (59)
Longevity (5)
Lung cancer (703)
Lymphoma (315)
Machine learning (25)
Management (3)
Manufacturing (211)
Marketing (2)
MASH (13)
Medical device (1059)
Medtech (1075)
Mergers & acquisitions (3659)
Metabolic disorders (164)
mRNA (98)
Multiple sclerosis (27)
NASH (1)
Neurodegenerative disease (56)
Neuropsychiatric disorders (9)
Neuroscience (473)
NextGen: Class of 2026 (1029)
Non-profit (573)
Now hiring (27)
Obesity (83)
Opinion (49)
Ovarian cancer (205)
Pain (35)
Pancreatic cancer (287)
Parkinson's disease (57)
Partnered (1)
Patents (142)
Patient recruitment (263)
Peanut (5)
People (14649)
Pharmaceutical (11)
Pharmacy benefit managers (4)
Phase 1 (8881)
Phase 2 (9890)
Phase 3 (7419)
Pipeline (3377)
Policy (52)
Postmarket research (493)
Preclinical (2837)
Press Release (2)
Prostate cancer (252)
Psychedelics (5)
Radiopharmaceuticals (250)
Rare diseases (201)
Real estate (819)
Recruiting (6)
Regulatory (5506)
Reports (10)
Research institute (787)
Resumes & cover letters (11)
RNA editing (4)
RSV (13)
Schizophrenia (41)
Series A (83)
Series B (48)
Service/supplier (1)
Sickle cell disease (43)
Special edition (5)
Spinal muscular atrophy (16)
Sponsored (7)
Startups (837)
State (1)
Stomach cancer (14)
Supply chain (19)
Tariffs (8)
The Weekly (25)
Vaccines (248)
Venture capital (49)
Weight loss (40)
Women's health (18)
Date
Today (32)
Last 7 days (138)
Last 30 days (574)
Last 365 days (9017)
2026 (5129)
2025 (8942)
2024 (10142)
2023 (11443)
2022 (14244)
2021 (14263)
2020 (12002)
2019 (9233)
2018 (6880)
2017 (7642)
2016 (6808)
2015 (7564)
2014 (4943)
2013 (3482)
2012 (3716)
2011 (3732)
2010 (3431)
Location
Africa (95)
Alabama (23)
Alaska (1)
Arizona (32)
Arkansas (3)
Asia (12234)
Australia (1720)
California (4280)
Canada (1009)
China (846)
Colorado (118)
Connecticut (169)
Delaware (303)
Europe (23159)
Florida (609)
Georgia (22)
Idaho (7)
Illinois (450)
India (37)
Indiana (152)
Iowa (11)
Japan (295)
Kansas (10)
Kentucky (15)
Louisiana (3)
Maine (5)
Maryland (435)
Massachusetts (3235)
Michigan (40)
Minnesota (155)
Missouri (21)
Montana (12)
Nebraska (3)
Nevada (11)
New Hampshire (12)
New Jersey (1179)
New Mexico (3)
New York (975)
North Carolina (297)
Northern California (2262)
Ohio (83)
Oklahoma (1)
Oregon (5)
Pennsylvania (666)
Puerto Rico (7)
Rhode Island (6)
South America (125)
South Carolina (7)
Southern California (1739)
Tennessee (56)
Texas (780)
United States (14240)
Utah (95)
Virginia (34)
Washington D.C. (9)
Washington State (386)
Wisconsin (49)
147,237 Results for "kineta immuno oncology".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Biovica Expands Japanese Patent Protection in Immuno-Oncology
July 16, 2026
·
2 min read
Press Releases
Biovica Granted Japanese Patent for Immuno-Oncology
July 1, 2026
·
2 min read
Press Releases
BostonGene to Feature Next-Generation AI Foundation Models for Precision Immuno-Oncology at the 22nd Annual RadMed Symposium
June 10, 2026
·
2 min read
Press Releases
Leads Biolabs R&D Symposium: Platform Synergy and Multi-Mechanism Integration Reshape the Immuno-Oncology Landscape
May 11, 2026
·
7 min read
Press Releases
Immuno-Oncology Investments Accelerate as Pipeline Catalysts Multiply in 2026
February 26, 2026
·
8 min read
Press Releases
Ipsen showcases transformative potential of early immuno-oncology pipeline at AACR
March 18, 2026
·
7 min read
Press Releases
Infinitopes Appoints Immuno-Oncology Pioneer Jo Brewer as Chief Scientific Officer (CSO) to Advance Therapeutic Pipeline From Clinical to Commercialisation
May 12, 2026
·
5 min read
Press Releases
BeyondSpring to Participate at the 12th Annual Immuno-Oncology 360° Conference
February 9, 2026
·
1 min read
Press Releases
Tonix Pharmaceuticals Presents Updates on Preclinical Immuno-Oncology Programs at the American Association for Cancer Research (AACR) Annual Meeting 2026
April 23, 2026
·
9 min read
Press Releases
Vyome Granted Chinese Patent Strengthening Immuno-Inflammation Portfolio
July 1, 2026
·
5 min read
1 of 14,724
Next
